"Designing Growth Strategies is in our DNA"

U.S. Interventional Oncology Market Size, Share & COVID-19 Impact Analysis, By Type (Radiation Therapy, Ablation Devices {Microwave Ablation, Radiofrequency Ablation, Cryoablation, and Others}, and Particle Embolization Devices {Microcatheters and Guidewires}), By Cancer Type (Lung Cancer, Liver Cancer, Kidney Cancer, and Others), By End-user (Hospitals, Specialty Clinics, and Others), and Country Forecast, 2023-2030

Last Updated: April 01, 2024 | Format: PDF | Report ID: FBI109199

 

KEY MARKET INSIGHTS

Play Audio Listen to Audio Version

The U.S. interventional oncology market size was worth USD 750.2 million in 2022 and is projected to grow at a CAGR of 7.8% during the forecast period. 


Interventional oncology utilizes minimally invasive techniques, such as tumor ablation and embolization, guided by imaging, to diagnose and treat cancer. It offers patients less invasive options with shorter recovery times and fewer side effects than traditional surgery. The U.S. has observed a significant rise in the prevalence of several forms of cancers, which has led to the increasing population seeking diagnosis and treatment. For instance, according to a research article published by the American Society of Clinical Oncology (ASCO), in the U.S., it was estimated that 288,300 men will be diagnosed with prostate cancer in 2023.


The rise in minimally-invasive procedures is due to the association of various benefits with these procedures, such as a minimal risk of infections, shorter hospital stays, and fewer complications, as compared to invasive surgeries, which are the major factors driving the demand for interventional oncology products.


The COVID-19 pandemic resulted in lower demand for ablation devices and particle embolization devices in 2020. This was due to the decrease in the number of visits of cancer patients to hospitals and lower oncology services during the pandemic. However, after the relaxation of the lockdown in the country, the resumption of interventional oncology treatments in healthcare facilities with the image guidance normalized the market in 2021 and 2022.


U.S. Interventional Oncology Market Trends


Growing Adoption of Radioembolization for the Oncology Treatment


In recent years, the market has witnessed a gradual increase in the adoption of radioembolization in minimally invasive procedures for the treatment of cancers. These interventional oncology procedures maximize the radiation to cancer cells while minimizing the damage to healthy tissues, leading to reduced side effects. In addition, this is effective for liver cancers, offering improved tumor control and potentially extending patient survival with fewer adverse effects compared to other treatments.


Furthermore, the market players are focusing on developing devices to attract a wider customer base by providing improved treatment facilities to oncologists. In addition, as the market players continue to embrace digital technologies, it is anticipated that the market for embolization devices will continue to foster the U.S. interventional oncology market growth.


U.S. Interventional Oncology Market Growth Factors


Growing Cancer Population to Boost the Demand for Minimally Invasive Procedures, Driving Market Growth


The growing cancer population has increased the demand for minimally invasive procedures, such as radiofrequency ablation, chemoembolization, and radioembolization. These techniques offer targeted treatment options, reducing the need for invasive surgery and the associated recovery times. Hence, these products’ effectiveness in treating cancers is expected to drive the demand for interventional oncology products.



  • For instance, according to the American Cancer Society, in 2022, the estimated number of kidney & renal pelvis cancer was 79,000 in the U.S.


Furthermore, cancer patients and healthcare providers increasingly favor interventional oncology for their effectiveness in treating various types of cancers, including liver, lung, and kidney cancers. This factor is increasing the adoption of minimally invasive procedures, thereby expected to boost the market growth during the forecast timeframe.


Request a Free sample to learn more about this report.


In the U.S., the estimated cases of lung & bronchus cancer and liver & intrahepatic bile duct cancer were 236,740 and 41,260 in 2022.


RESTRAINING FACTORS


High Cost of Procedures May Hinder Market Growth


Despite the increased adoption of minimally invasive cancer treatments in the country, the high costs associated with this cancer treatment may hamper the adoption of products in the U.S. interventional oncology market. Moreover, the cost of these procedures varies depending on their features and type, with certain advanced products costing several thousand dollars. These factors act as significant barriers to their adoption in hospitals and specialty clinics in the country.


For instance, according to the study published by the Journal of the American College of Radiology in August 2021, the costs of ablation increased from USD 3,288 to USD 4,461 for tumor treatment.


U.S. Interventional Oncology Market Segmentation Analysis


By Type Analysis


Based on type, the market is segmented into radiation therapy, ablation devices, and particle embolization devices.


The radiation therapy segment dominated the market in 2022. The segmental growth is attributed to the various benefits associated with the device, such as its ability to provide targeted and precise tumor control, including minimizing damage to the surrounding healthy tissues. Furthermore, the growing preference for minimally invasive procedures is expected to boost the adoption of these products in the U.S. market for interventional oncology.


The particle embolization devices segment is expected to grow at the highest CAGR during the forecast period. The growth is attributed to the introduction of products and the growing demand for advanced products for the treatment of cancer in the country.



  • For instance, in November 2023, Fluidx Medical Technology, Inc. announced the development of the Ultra peripheral embolic platform for addressing hemorrhage, tumor treatment, and other proximal embolization applications.


By Cancer Type Analysis


Based on cancer type, the market is segmented into lung cancer, liver cancer, kidney cancer, and others.


The liver cancer segment accounted for the largest U.S. interventional oncology market share in 2022 due to the increasing number of patients suffering from liver cancer in the country. This is expected to drive the demand for minimally invasive treatments, thereby propelling the segment growth during the forecast period.



  • For instance, according to the data published by the American Cancer Society in the U.S., the new cases of liver & intrahepatic bile duct cancer were estimated to be 42,230 in 2021. Some of the most common types of liver cancers include hepatocellular carcinoma and intrahepatic bile duct cancers. Such a high burden of cancer is expected to boost the market growth during the forecast period.


By End-user Analysis


Based on end-user, the market is segmented into specialty clinics, hospitals, and others.


The hospitals segment is expected to grow at a notable CAGR during the forecast period and accounts for the largest share. The segment’s growth is owed to the increasing number of patient visits for cancer treatment to the hospitals and increasing demand for comprehensive cancer care services, which are poised to boost the segmental growth during the forecast period. Furthermore, the increasing focus of hospitals on cancer care is expected to boost the segmental growth.


List of Key Companies in U.S. Interventional Oncology Market


The U.S. interventional oncology market depicts the presence of established and emerging companies. Leading players in the market, such as Boston Scientific Corporation, Terumo Corporation, and Siemens Healthineers hold a significant share of the market. These market players are focusing on the establishment of new strategies, such as product launches, new subsidiaries, mergers, and acquisitions, in order to grow their footprints in the market.


Some other companies with a considerable presence in the U.S. market include Merit Medical Systems, BD, and other small & mid-sized players. These companies are focusing on the introduction of novel products, which is expected to boost their share in the U.S. market for interventional oncology.


An Infographic Representation of U.S. Interventional Oncology Market

To get information on various segments, share your queries with us



LIST OF KEY COMPANIES PROFILED:



KEY INDUSTRY DEVELOPMENTS:



  • August 2023: Boston Scientific Corporation received approval from the U.S. FDA for a cryoablation system known as POLARx.

  • September 2022: Fluidx Medical Technology, Inc. completed trial registration for its GPX embolization device. In multicenter studies, GPX has been used to treat multiple adrenal tumors, primary and metastatic tumors, and tumors in the arteries and veins.

  • September 2022: Stryker announced that its OptaBlate bone tumor ablation system (OptaBlate) received 510(k) clearance from the U.S. FDA.


REPORT COVERAGE


The U.S. interventional oncology market research report provides a detailed analysis of the market. It also provides information related to key industry developments such as mergers and acquisitions and market dynamics, including drivers, restraints, and growth opportunities. In addition, it includes an overview of the technological advancements in the market and the prevalence of key cancer in the country. Moreover, the impact of COVID-19 and the industry overview during the pandemic and post-pandemic are covered in the report.


To gain extensive insights into the market, Request for Customization


Report Scope & Segmentation
















































ATTRIBUTE



DETAILS



Study Period



2019-2030



Base Year



2022



Estimated Year



2023



Forecast Period



2023-2030



Historical Period



2019-2021



Growth Rate



CAGR of 7.8% from 2023 to 2030



Unit



Value (USD Million)



Segmentation



By Type



  • Radiation Therapy

  • Ablation Devices

    • Microwave ablation

    • Radiofrequency ablation

    • Cryoablation

    • Others



  • Particle Embolization Devices

    • Microcatheters

    • Guidewires





By Cancer Type



  • Lung Cancer

  • Liver Cancer

  • Kidney Cancer

  • Others



By End-user



  • Hospitals

  • Specialty Clinics

  • Others






Frequently Asked Questions

Fortune Business Insights says that the U.S. market was worth USD 750.2 million in 2022.

The market is expected to exhibit a CAGR of 7.8% during the forecast period (2023-2030).

By type, the radiation therapy segment leads and dominated in 2022.

Siemens Healthineers, Boston Scientific Corporation, and Terumo Corporation are the prominent players in the market.

Seeking Comprehensive Intelligence on Different Markets?
Get in Touch with Our Experts

Speak to an Expert
  • 2019-2030
  • 2022
  • 2019-2021
  • 70

Personalize this Research

  • Granular Research on Specified Regions or Segments
  • Companies Profiled based on User Requirement
  • Broader Insights Pertaining to a Specific Segment or Region
  • Breaking Down Competitive Landscape as per Your Requirement
  • Other Specific Requirement on Customization
Request Customization Banner

Client Testimonials

“We are quite happy with the methodology you outlined. We really appreciate the time your team has spent on this project, and the efforts of your team to answer our questions.”

- One of the largest & renowned medical research centers based in the U.S. on a report on the U.S. NIPT Market.

“Thanks a million. The report looks great!”

- Feedback from a consultant on a report on the U.S. Beef Market.

“Thanks for the excellent report and the insights regarding the lactose market.”

- Brazil based company specializing in production of protein ingredients.

“I liked the report; would it be possible to send me the PPT version as I want to use a few slides in an internal presentation that I am preparing.”

- Global Digital Services Agency on a report on the Global Luxury Goods Market.

“This report is really well done and we really appreciate it! Again, I may have questions as we dig in deeper. Thanks again for some really good work.”

- U.S.-based biotechnology company focussing on treatment of chronic pain.

“Kudos to your team. Thank you very much for your support and agility to answer our questions.”

- Europe-based provider of solutions to automate data centre operations.

“We appreciate you and your team taking out time to share the report and data file with us, and we are grateful for the flexibility provided to modify the document as per request. This does help us in our business decision making. We would be pleased to work with you again, and hope to continue our business relationship long into the future.”

- India-based manufacturer of industrial and specialty intermediates with a strong global presence.

“I want to first congratulate you on the great work done on the Medical Platforms project. Thank you so much for all your efforts.”

- One of the largest cosmetics company in the world.

“Thank you very much. I really appreciate the work your team has done. I feel very comfortable recommending your services to some of the other startups that I’m working with, and will likely establish a good long partnership with you.”

- U.S. based startup operating in the cultivated meat market.

“We received the below report on the U.S. market from you. We were very satisfied with the report.”

- Global hearing aids manufacturer.

“I just finished my first pass-through of the report. Great work! Thank you!”

- U.S. based solar racking solutions provider.

“Thanks again for the great work on our last partnership. We are ramping up a new project to understand the imaging and imaging service and distribution market in the U.S.”

- World’s leading advisory firm.

“We feel positive about the results. Based on the presented results, we will do strategic review of this new information and might commission a detailed study on some of the modules included in the report after end of the year. Overall we are very satisfied and please pass on the praise to the team. Thank you for the co-operation!”

- Germany based machine construction company.

“Thank you very much for the very good report. I have another requirement on cutting tools, paper crafts and decorative items.”

- Japanese manufacturing company of stationery products.

“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”

- One of the Leading Food Companies in Germany

“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”

- Intuitive Surgical

“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”

- Major Food Company in Japan

“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”

- Ziering Medical

“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”

- Major Manufacturer of Precision Machine Parts in India

“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”

- Hewlett-Packard

“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”

- Global Management Consulting Firm

“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”

- UK-based Start-up in the Medical Devices Sector

“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”

- One of the Largest Companies in the Defence Industry
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . Privacy.
X